Rbm5 sustains leukemia stem cells through a Myc-driven transcriptional circuitry

Area of Science:

• Hematology
• Molecular Biology
• Cancer Research

Background:

• Acute myeloid leukemia (AML) is driven by leukemia stem cells (LSCs).
• Understanding LSC self-renewal mechanisms is crucial for AML therapy.

Purpose of the Study:

• Investigate the role of RNA-binding protein Rbm5 in AML.
• Determine Rbm5's mechanism in maintaining LSC self-renewal.

Main Methods:

• Studied Rbm5 expression in LSCs and normal hematopoietic stem cells (HSCs).
• Assessed LSC function and differentiation upon Rbm5 deficiency.
• Identified Myc as a direct transcriptional target of Rbm5.

Main Results:

• Rbm5 is highly expressed in LSCs and promotes leukemogenesis.
• Rbm5 deficiency impairs LSC self-renewal and induces differentiation.
• Rbm5 directly regulates Myc protein levels and downstream gene expression in LSCs.
• Myc expression rescues Rbm5-depleted LSC defects.

Conclusions:

• Rbm5 sustains the AML LSC self-renewal program via the Myc transcriptional network.
• Rbm5's role is specific to LSCs, not normal HSCs.
• Rbm5 represents a potential therapeutic target for AML.